Paper23932191
Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
Groselj B and 2 others. Radiother Oncol, 2013. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression. Papers, record 23932191. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23932191
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Nuclear | Major topic |
| DNA-Binding Proteins | Major topic |
| Hydroxamic Acids | Major topic |
| Indoles | Major topic |
| Radiation-Sensitizing Agents | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Cell Cycle Checkpoints | |
| Cell Line, Tumor | |
| Histones | |
| Humans | |
| Ku Autoantigen | |
| MRE11 Homologue Protein | |
| Panobinostat | |
| Rad51 Recombinase |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 12933 | Cancer Research UK | United Kingdom | PubMed | |
| C5255/A15935 | Cancer Research UK | United Kingdom | PubMed |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21704409 | Retention of γH2AX foci as an indication of lethal DNA damage. | Radiother Oncol | 2011 | https://conductscience.org/library/papers/21704409 | PubMed |
| 2 | 12897142 | Pathways of DNA double-strand break repair during the mammalian cell cycle. | Mol Cell Biol | 2003 | https://conductscience.org/library/papers/12897142 | PubMed |
| 3 | 15466592 | DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining. | Nucleic Acids Res | 2004 | https://conductscience.org/library/papers/15466592 | PubMed |
| 4 | 20139725 | gammaH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization. | Cell Cycle | 2010 | https://conductscience.org/library/papers/20139725 | PubMed |
| 5 | 21454009 | Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. | Eur Urol | 2011 | https://conductscience.org/library/papers/21454009 | PubMed |
| 6 | 23433795 | Detection and repair of ionizing radiation-induced DNA double strand breaks: new developments in nonhomologous end joining. | Int J Radiat Oncol Biol Phys | 2013 | https://conductscience.org/library/papers/23433795 | PubMed |
| 7 | 23551441 | The emerging role of histone deacetylase (HDAC) inhibitors in urological cancers. | BJU Int | 2013 | https://conductscience.org/library/papers/23551441 | PubMed |
| 8 | 11314007 | Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies. | Oncogene | 2001 | https://conductscience.org/library/papers/11314007 | PubMed |
| 9 | 21903282 | The receptor tyrosine kinase inhibitor amuvatinib (MP470) sensitizes tumor cells to radio- and chemo-therapies in part by inhibiting homologous recombination. | Radiother Oncol | 2011 | https://conductscience.org/library/papers/21903282 | PubMed |
| 10 | 16000590 | Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/16000590 | PubMed |
| 11 | 23361058 | Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair. | Br J Cancer | 2013 | https://conductscience.org/library/papers/23361058 | PubMed |
| 12 | 9697414 | Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. | Trends Biochem Sci | 1998 | https://conductscience.org/library/papers/9697414 | PubMed |
| 13 | 21227757 | Two unrelated patients with MRE11A mutations and Nijmegen breakage syndrome-like severe microcephaly. | DNA Repair (Amst) | 2011 | https://conductscience.org/library/papers/21227757 | PubMed |
| 14 | 21277099 | Adamantanyl-histone deacetylase inhibitor H6CAHA exhibits favorable pharmacokinetics and augments prostate cancer radiation sensitivity. | Int J Radiat Oncol Biol Phys | 2011 | https://conductscience.org/library/papers/21277099 | PubMed |
| 15 | 19105236 | Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA-binding activities. | Genes Chromosomes Cancer | 2009 | https://conductscience.org/library/papers/19105236 | PubMed |
| 16 | 20679231 | Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20679231 | PubMed |
| 17 | 23302228 | Imatinib radiosensitizes bladder cancer by targeting homologous recombination. | Cancer Res | 2013 | https://conductscience.org/library/papers/23302228 | PubMed |
| 18 | 16899611 | A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16899611 | PubMed |
| 19 | 12888535 | Development of a rapid, small-scale DNA repair assay for use on clinical samples. | Nucleic Acids Res | 2003 | https://conductscience.org/library/papers/12888535 | PubMed |
| 20 | 17904301 | Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center. | Int J Radiat Oncol Biol Phys | 2008 | https://conductscience.org/library/papers/17904301 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42717345 | Targeting E3 ubiquitin ligases: Mechanistic breakthroughs and novel clinical translation pathways for tumor radioimmunotherapy. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42717345 | PubMed |
| 41268758 | Techniques to study chimerism at the tissue level in humanized mice. | Vet Pathol | 2026 | https://conductscience.org/library/papers/41268758 | PubMed |
| 38794172 | Mechanistic Sequence of Histone Deacetylase Inhibitors and Radiation Treatment: An Overview. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38794172 | PubMed |
| 37497216 | E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies. | Front Immunol | 2023 | https://conductscience.org/library/papers/37497216 | PubMed |
| 36810912 | Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling. | Br J Cancer | 2023 | https://conductscience.org/library/papers/36810912 | PubMed |
| 36497040 | 4-Methylumebelliferone Enhances Radiosensitizing Effects of Radioresistant Oral Squamous Cell Carcinoma Cells via Hyaluronan Synthase 3 Suppression. | Cells | 2022 | https://conductscience.org/library/papers/36497040 | PubMed |
| 35737378 | Characterization of Double-Strand Break Repair Protein Ku80 Location Within the Murine Retina. | Invest Ophthalmol Vis Sci | 2022 | https://conductscience.org/library/papers/35737378 | PubMed |
| 34708131 | Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes. | J Immunol Res | 2021 | https://conductscience.org/library/papers/34708131 | PubMed |
| 34471236 | SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis. | Oncogene | 2021 | https://conductscience.org/library/papers/34471236 | PubMed |
| 34358096 | Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34358096 | PubMed |
| 33806487 | Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells. | Cells | 2021 | https://conductscience.org/library/papers/33806487 | PubMed |
| 32784607 | The Chromatin Response to Double-Strand DNA Breaks and Their Repair. | Cells | 2020 | https://conductscience.org/library/papers/32784607 | PubMed |
| 32012885 | Targeting the Immune system and Epigenetic Landscape of Urological Tumors. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32012885 | PubMed |
| 31516745 | Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer. | Cancer Biol Med | 2019 | https://conductscience.org/library/papers/31516745 | PubMed |
| 30875794 | Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30875794 | PubMed |
| 30837601 | Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [18F]TFAHA. | Sci Rep | 2019 | https://conductscience.org/library/papers/30837601 | PubMed |
| 29888979 | Radiation biology and oncology in the genomic era. | Br J Radiol | 2018 | https://conductscience.org/library/papers/29888979 | PubMed |
| 29532618 | Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma. | Cancer Med | 2018 | https://conductscience.org/library/papers/29532618 | PubMed |
| 28839000 | Radiosensitization In Vivo by Histone Deacetylase Inhibition with No Increase in Early Normal Tissue Radiation Toxicity. | Mol Cancer Ther | 2018 | https://conductscience.org/library/papers/28839000 | PubMed |
| 27631103 | Acetylation Reader Proteins: Linking Acetylation Signaling to Genome Maintenance and Cancer. | PLoS Genet | 2016 | https://conductscience.org/library/papers/27631103 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23932191
GET https://conductscience.org/api/papers/v1/23932191/references?page=2